As of March 2025 Ultragenyx Pharmaceutical has a market cap of S$4.69 Billion. This makes Ultragenyx Pharmaceutical the world's 3252th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | S$4.69 B | -13.83% |
2024 | S$5.45 B | 5.09% |
2023 | S$5.18 B | 19.1% |
2022 | S$4.35 B | -43.81% |
2021 | S$7.74 B | -36.04% |
2020 | S$12.11 B | 263.79% |
2019 | S$3.33 B | 10.24% |
2018 | S$3.02 B | 14.35% |
2017 | S$2.64 B | -36.46% |
2016 | S$4.15 B | -32.61% |
2015 | S$6.16 B | 233.22% |
2014 | S$1.85 B |
On Mar 29th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be: